The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An assessment of the penile squamous cell carcinoma surfaceome for therapeutic target discovery.
 
George Daniel Grass
Stock and Other Ownership Interests - Beam Therapeutics; Editas Medicine; Intellia Therapeutics; Lantheus Medical Imaging
Patents, Royalties, Other Intellectual Property - Pending patent for radiation-immune signature
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Exelixis; Pfizer
 
Dalia Ercan
No Relationships to Disclose
 
Alyssa Obermayer
No Relationships to Disclose
 
Timothy Shaw
No Relationships to Disclose
 
Paul Stewart
No Relationships to Disclose
 
Peter A.S. Johnstone
No Relationships to Disclose
 
Silvia Regina Rogatto
No Relationships to Disclose
 
Steven A. Eschrich
Employment - Cvergenx
Leadership - CvergenX
Stock and Other Ownership Interests - CvergenX
Patents, Royalties, Other Intellectual Property - August 1, 2017, Gillies, Robert J.; Eschrich, Steven A.; Gatenby, Robert A.; Lambin, Philippe; Dekker, Andre L. A. J.; Napel, Sandy A.; Plevritis, Sylvia; Rubin, Daniel L., “Systems, Methods and Devices for Analyzing Quantitative Information Obtained from; February 4, 2014, Yeatman, Timothy J.; Zhou, Jeff Xiwu; Bloom, Gregory C,; Eschrich, Steven A, “Artificial Neural Network Proteomic Tumor Classification”, U.S. Patent No. 8,642,349.; January 15, 2019, Yeatman, Timothy; Bloom, Gregory C., Eschrich, Steven A, “Methods and Systems for Predicting Cancer Outcome”, U.S. Patent No. 10,181,009.; Patents on RSI, radiation sensitivity technology.
Travel, Accommodations, Expenses - CvergenX
(OPTIONAL) Uncompensated Relationships - Cvergenx
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center